Listando Facultat de Ciències de la Salut Blanquerna por materia "Mama -- Càncer"

Mostrando ítems 1-2 de 2

    • Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: preclinical and real-life clinical data 

      Bernat Peguera, Adrià; Trigueros Peña, Macedonia; Ferrando Díez, Angelica; Ibáñez, Cristina; Bystrup, Sara; Martínez-Cardús, Anna; Margelí, Mireia; Martínez-Balibrea, Eva (The Breast, 2022, 62: 1-9, 2022-01)
      After the expiration of trastuzumab data exclusivity, biosimilar drugs were approved by regulatory agencies; among them, CT-P6 which was approved for the treatment of HER2-positive early- and advanced-breast ...

    • Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study 

      Castro Espin, Carlota; Agudo, Antonio; Bonet, Catalina; Katzke, Verena Andrea; Turzanski‑Fortner, Renée; Aleksandrova, Krasimira; Schulze, Matthias B.; Tjønneland, Anne; Dahm, Christina C.; Quirós, José Ramón; Sánchez, María-José; Amiano, Pilar; Chirlaque, Maria-Dolores; Ardanaz, Eva; Masala, Giovanna; Sieri, Sabina; Tumino, Rosario; Sacerdote, Carlotta; Panico, Salvatore; May, Anne-Marie; Bodén, Stina; Gram, Inger Torhild; Skeie, Guri; Laouali, Nasser; Shah, Sanam; Severi, Gianluca; Aune, Dagfnn; Merritt, Melissa; Cairat, Manon; Weiderpass, Elisabete; Riboli, Elio; Dossus, Laure; Jakszyn, Paula (European Journal of Epidemiology, 2021, 36: 953-964, 2021-06)
      The role of chronic infammation on breast cancer (BC) risk remains unclear beyond as an underlying mechanism of obesity and physical activity. We aimed to evaluate the association between the infammatory ...